ACL surgery under the microscope: 5-Year study tracks recovery

NCT ID NCT03441659

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 1000 patients who have ACL reconstruction surgery to see how their knees hold up over time. Researchers check knee stability and quality of life before surgery and at 6 months, 1, 2, and 5 years after. The goal is to better understand long-term recovery and function after this common procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could provide clearer evidence on how well ACL reconstruction works over the long term, helping doctors and patients make better treatment decisions.

What could go wrong

This is an observational follow-up study, not a test of a new treatment. Results may not apply to all patients, and there is no guarantee of improved outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACL INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Anterior Cruciate Ligament Injuries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Stefano Zaffagnini

    RECRUITING

    Bologna, Italia, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••